S
Stanley Gill
Researcher at Harvard University
Publications - 7
Citations - 2225
Stanley Gill is an academic researcher from Harvard University. The author has contributed to research in topics: Gene & Genome. The author has an hindex of 6, co-authored 7 publications receiving 1420 citations. Previous affiliations of Stanley Gill include Broad Institute.
Papers
More filters
Journal ArticleDOI
Defining a Cancer Dependency Map
Aviad Tsherniak,Francisca Vazquez,Francisca Vazquez,Phil Montgomery,Barbara A. Weir,Barbara A. Weir,Gregory Kryukov,Gregory Kryukov,Glenn S. Cowley,Stanley Gill,Stanley Gill,William F. Harrington,Sasha Pantel,John M. Krill-Burger,Robin M. Meyers,Levi D. Ali,Amy Goodale,Yenarae Lee,Guozhi Jiang,Jessica Hsiao,William F.J Gerath,Sara Howell,Erin Merkel,Mahmoud Ghandi,Levi A. Garraway,David E. Root,Todd R. Golub,Jesse S. Boehm,William C. Hahn +28 more
TL;DR: DEMETER, an analytical framework that segregates on- from off-target effects of RNAi, demonstrates the basis behind one such predictive model linking hypermethylation of the UBB ubiquitin gene to a dependency on UBC and provides a foundation for a cancer dependency map that facilitates the prioritization of therapeutic targets.
Journal ArticleDOI
Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting
Andrew J. Aguirre,Robin M. Meyers,Barbara A. Weir,Francisca Vazquez,Cheng-Zhong Zhang,Uri Ben-David,April Cook,Gavin Ha,William F. Harrington,Mihir B. Doshi,Maria Kost-Alimova,Stanley Gill,Han Xu,Levi D. Ali,Guozhi Jiang,Sasha Pantel,Yenarae Lee,Amy Goodale,Andrew D. Cherniack,Coyin Oh,Gregory V. Kryukov,Glenn S. Cowley,Levi A. Garraway,Kimberly Stegmaier,Charles W. M. Roberts,Todd R. Golub,Matthew Meyerson,David E. Root,Aviad Tsherniak,William C. Hahn +29 more
TL;DR: It is found that the number of CRISPR/Cas9-induced DNA breaks dictates a gene-independent antiproliferative response in cells, which has practical implications for using CRISpr/cas9 to interrogate cancer gene function and illustrate that cancer cells are highly sensitive to site-specific DNA damage, which may provide a path to novel therapeutic strategies.
Journal ArticleDOI
Complementary information derived from CRISPR Cas9 mediated gene deletion and suppression
Joseph Rosenbluh,Han Xu,William F. Harrington,Stanley Gill,Stanley Gill,Xiaoxing Wang,Xiaoxing Wang,Francisca Vazquez,Francisca Vazquez,David E. Root,Aviad Tsherniak,William C. Hahn,William C. Hahn +12 more
TL;DR: It is concluded that CRISPRc and CRISpri have different off-target effects and combining these approaches provides complementary information in loss-of-function genetic screens.
Journal ArticleDOI
Predicting cell health phenotypes using image-based morphology profiling.
Gregory P. Way,Maria Kost-Alimova,Tsukasa Shibue,William F. Harrington,Stanley Gill,Federica Piccioni,Tim Becker,Hamdah Shafqat-Abbasi,William C. Hahn,Anne E. Carpenter,Francisca Vazquez,Shantanu Singh +11 more
TL;DR: Simple machine learning algorithms can predict many cell health readouts directly from Cell Painting images, at less than half the cost, and can be used to add cell health annotations to Cell Painting datasets.
Journal ArticleDOI
Genome-Wide Interrogation of Human Cancers Identifies EGLN1 Dependency in Clear Cell Ovarian Cancers.
Colles Price,Colles Price,Stanley Gill,Stanley Gill,Zandra V. Ho,Shawn M. Davidson,Shawn M. Davidson,Erin Merkel,James M. McFarland,Lisa Leung,Andrew Tang,Maria Kost-Alimova,Aviad Tsherniak,Oliver Jonas,Oliver Jonas,Francisca Vazquez,Francisca Vazquez,William C. Hahn +17 more
TL;DR: Findings reveal a differential dependency of clear cell ovarian cancers on EGLN1, thus identifying E GLN1 as a potential therapeutic target in clear cell Ovarian cancer patients.